References
- Gallimore M. J., Amundsen E., Larsbraaten M., Lyngaas K., Fareid E. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays. Thrombosis Res 1979; 16: 695–703
- Gallimore M. J., Fareid E., Stormorken H. The purification of a human plasma kallikrein with weak plasminogen activator activity. Thrombosis Res 1978; 12: 409–420
- Aasen A. O., Smith-Erichsen N., Gallimore M. J., Amundsen E. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. Advances in Shock Research. Alan R. Liss Inc., New York 1980; Vol. IV: 1–10
- Walker I. D., Gallimore M. J., Imrie C. W., Davidson J. F. The coagulation, fibrinolytic and plasma kallikrein systems in acute pancreatitis. Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 5, In press
- Amundsen E., Gallimore M. J., Aasen A. O., Larsbraaten M., Lyngaas K. Activation of human plasma prekallikrein: Influence of activators, activation time and inhibitors. Thrombosis Res 1978; 13: 625–636
- Aasen A. O., Personal communication
- Teger-Nilsson A-C., Personal communication
- Kaplan A. P., Meier H. L., Mandle R., Jr. The Hageman factor dependent pathways of coagulation, fibrinolysis and kinin generation. Semin. Thromb. Haemostas 1976; 3: 1–26
- Schreiber A. D. Plasma inhibitors of the Hageman factor dependent pathways. Semin. Thromb. Haemostas 1976; 3: 43–51
- Pensky I., Levy L. R., Lepow I. H. Partial purification of a serum inhibitor of C1′-esterase. J. Biol. Chem 1961; 236: 1674–1679